tiprankstipranks
Trending News
More News >
Myriad Genetics (MYGN)
NASDAQ:MYGN

Myriad Genetics (MYGN) Revenue

Compare
386 Followers

Myriad Genetics Revenue

Myriad Genetics had a revenue of 213.30M in the quarter ending Sep 30, 2024, with 0.85%. This bring the company's revenue in the last twelve months to 823.60M, Decreased 2.67%. In the fiscal year ending Dec 31, 2023, Myriad Genetics had annual revenue of 753.20M with 11.03% growth.
Revenue (ttm)
823.60M
Revenue Growth
12.15%
P/S Ratio
0.51
Revenue/Employee
$278,963
Employees
2,700
Market Cap
$380.69M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
753.20M74.80M+11.03%
Dec 31, 2022
678.40M-12.20M-1.77%
Dec 31, 2021
690.60M133.60M+23.99%
Dec 31, 2020
557.00M-294.10M-34.56%
Jun 30, 2020
851.10M0.000.00%
Jun 30, 2019
851.10M78.50M+10.16%
Jun 30, 2018
772.60M1.20M+0.16%
Jun 30, 2017
771.40M17.60M+2.33%
Jun 30, 2016
753.80M30.70M+4.25%
Jun 30, 2015
723.10M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis